Randall Moreadith Age X Therapeutics, Inc. (AGE) insider trading activity

AGE Quotes by TradingView

Randall Moreadith is Chief Scientific Officer of AgeX Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AGE, which is worth approximately $0. The most recent transaction as insider was on Nov 10, 2025, when has been sold 6,500 shares (Common Stock) at a price of $0.06 per share, resulting in proceeds of $390. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Randall Moreadith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 10 2025
BUY
Exercise of conversion of derivative security
$390 $0.06 p/Share
6,500 Added 50.0%
6,500 Common Stock
Nov 05 2025
SELL
Open market or private sale
$14,407 $4.24 p/Share
3,398 Reduced 100.0%
0 Common Stock
Nov 05 2025
BUY
Exercise of conversion of derivative security
$203 $0.06 p/Share
3,398 Added 50.0%
3,398 Common Stock
Nov 04 2025
SELL
Open market or private sale
$13,648 $4.4 p/Share
3,102 Reduced 100.0%
0 Common Stock
Nov 04 2025
BUY
Exercise of conversion of derivative security
$186 $0.06 p/Share
3,102 Added 50.0%
3,102 Common Stock
Oct 28 2025
SELL
Open market or private sale
$27,532 $4.96 p/Share
5,551 Reduced 100.0%
0 Common Stock
Oct 28 2025
BUY
Exercise of conversion of derivative security
$333 $0.06 p/Share
5,551 Added 50.0%
5,551 Common Stock
Oct 27 2025
SELL
Open market or private sale
$4,925 $5.19 p/Share
949 Reduced 100.0%
0 Common Stock
Oct 27 2025
BUY
Exercise of conversion of derivative security
$56 $0.06 p/Share
949 Added 50.0%
949 Common Stock
Oct 20 2025
SELL
Open market or private sale
$32,305 $4.97 p/Share
6,500 Reduced 100.0%
0 Common Stock
Oct 20 2025
BUY
Exercise of conversion of derivative security
$390 $0.06 p/Share
6,500 Added 50.0%
6,500 Common Stock
Oct 13 2025
SELL
Open market or private sale
$22,495 $5.2 p/Share
4,326 Reduced 100.0%
0 Common Stock
Oct 13 2025
BUY
Exercise of conversion of derivative security
$259 $0.06 p/Share
4,326 Added 50.0%
4,326 Common Stock
Aug 26 2025
SELL
Open market or private sale
$319,880 $7.01 p/Share
45,632 Reduced 100.0%
0 Common Stock
Aug 26 2025
BUY
Exercise of conversion of derivative security
$2,737 $0.06 p/Share
45,632 Added 50.0%
45,632 Common Stock
Aug 25 2025
SELL
Open market or private sale
$11,537 $5.65 p/Share
2,042 Reduced 100.0%
0 Common Stock
Aug 25 2025
BUY
Exercise of conversion of derivative security
$122 $0.06 p/Share
2,042 Added 50.0%
2,042 Common Stock
Aug 20 2025
SELL
Open market or private sale
$10,592 $5.1 p/Share
2,077 Reduced 100.0%
0 Common Stock
Aug 20 2025
BUY
Exercise of conversion of derivative security
$124 $0.06 p/Share
2,077 Added 50.0%
2,077 Common Stock
Aug 18 2025
SELL
Open market or private sale
$11,691 $5.25 p/Share
2,227 Reduced 100.0%
0 Common Stock
Aug 18 2025
BUY
Exercise of conversion of derivative security
$133 $0.06 p/Share
2,227 Added 50.0%
2,227 Common Stock
Aug 12 2025
SELL
Open market or private sale
$28,875 $5.25 p/Share
5,500 Reduced 100.0%
0 Common Stock
Aug 12 2025
BUY
Exercise of conversion of derivative security
$330 $0.06 p/Share
5,500 Added 50.0%
5,500 Common Stock
Aug 04 2025
SELL
Open market or private sale
$28,435 $5.17 p/Share
5,500 Reduced 100.0%
0 Common Stock
Aug 04 2025
BUY
Exercise of conversion of derivative security
$330 $0.06 p/Share
5,500 Added 50.0%
5,500 Common Stock
RM

Randall Moreadith

Chief Scientific Officer
Huntsville, AL

Track Institutional and Insider Activities on AGE

Follow AgeX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGE shares.

Notify only if

Insider Trading

Get notified when an Age X Therapeutics, Inc. insider buys or sells AGE shares.

Notify only if

News

Receive news related to AgeX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGE